JanOne

JanOne - A New Day for Treatments That Kill Pain, Not People #JanOne (Nasdaq: $JAN)

[JanOne @janone]

JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients

Read the full news release here: https://t.co/MTwYEooZJJ $JAN #PAD #Healthcare #Science

[JanOne @janone]

JanOne Readies #Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites

Read the full news release here: https://t.co/aDKvdKUFLd $JAN #PAD #Medical #Healthcare #Research

[JanOne @janone]

JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing

Read the full news release here: https://t.co/xaeqCxZAAs $JAN #PAD #Healthcare #Medical

[JanOne @janone]

JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board

Read the full news release here: https://t.co/yZ3a5v6Ozs $JAN #Healthcare #Medical

[JanOne @janone]

JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives

Read the full news release here: https://t.co/09Zq2k4pqj $JAN #Healthcare #Medical

[JanOne @janone]

Our CSO, Dr. Giordano, sat down with @EricDye to discuss JanOne, the treatment of #PAD, bringing to market drugs with non-addictive pain-relieving properties, and more. $JAN #PADAwareness #Healthcare #Medical

Listen to the interview here via @eHealthRadio https://t.co/37KgqBny2o

[JanOne @janone]

JanOne Successfully Begins Production of #JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (#PAD) Trial and Potential #Covid19 Study.

Read the full news release here: https://t.co/70as1jkwv9 $JAN #Treatment #Medical #Health

[JanOne @janone]

JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent #Pharma Asset Potential for Peripheral Artery Disease. Read the full news release here: https://t.co/mlzBCiDnL7 $JAN #PAD #Treatments #Healthcare #JAN101

[JanOne @janone]

When treating #PAD associated pain, 25% of patients are at risk for opioid prescriptions. If we treat PAD at the source, we remove the need for pain-relieving #medications. Learn more here: https://t.co/bG5vEEVdY5 $JAN #PADAwareness #PADAwarenessMonth #Healthcare

[JanOne @janone]

JanOne Announces Strategic Plan to Divest its Legacy Businesses.

Read the full news release here: https://t.co/Oo2sjF9hBI $JAN #PAD #COVIDー19 #JAN101

[JanOne @janone]

Our first drug candidate is being tested to treat #PAD. We have assembled an amazing team of experts in vascular #science and #pain. Learn more here: https://t.co/bsv1HxzsuS $JAN #PADAwareness

[American College of Cardiology @ACCinTouch]

Join the ACC in recognizing #PADAwareness Month. The PAD Condition Center located on @CardioSmart’s new website provides information for patients to better understand their condition, resources to find support, questions to ask their physicians, and more: https://t.co/qVFZAegAOI

[JanOne @janone]

It's #PADAwareness Month. Click the link to learn more about Peripheral Artery Disease, the signs and symptoms and what you can do to help manage #PAD via @CardioSmart https://t.co/kbBoChEvxE $JAN

[JanOne @janone]

Thank you, @OutsourcPharma, for featuring our latest news about our developmental batch of JAN101, aimed to potentially treat #cardiovascular conditions and #COVID19 https://t.co/wfNr4Zseme $JAN #Coronavirus #Healthcare #PatientCare

[JanOne @janone]

JanOne Inc to ramp up production of its lead therapy JAN101 as a potential #coronavirus treatment via @proactive_NA $JAN #healthcare #COVID19 #Covid_19 https://t.co/jNhhWKjLls

[JanOne @janone]

Our CSO will at the LD 500 today at 3 PM ET to discuss upcoming developments, an overview of our drug candidate JAN101 for the potential treatment of #peripheralarterydisease #PAD & #COVID19 vascular complications & more $JAN Register here: https://t.co/V2xKCdm9Ke #Covid_19

[JanOne @janone]

JanOne confirms stability data of JAN101 development batch and prepares for commercial GMP production to support the upcoming #PAD and potential #Covid19 clinical trials $JAN #Healthcare #coronavirus #ClinicalResearch

Read the full news release here: https://t.co/P07YiMunyV

[Pharmaceutical Processing World @PharmaProWorld]

.@janone recently announced that it has forged a partnership with a company to bottle and label its JAN101 drug https://t.co/j8YbBNaOA0

[JanOne @janone]

JanOne selects partner for bottling for #PAD drug via @PharmaProWorld https://t.co/Femm3fClP5 $JAN #Healthcare #Pharma #COVID19 #Vascular

[JanOne @janone]

Our CMO, Dr. Soin, joined Money Info with Charles Moscowitz via WPSL AM to discuss our #technology, #painmanagement with JAN1010, the ongoing #opioid crisis, COVID19 related #vascular problems and more. Tune in for the full interview below https://t.co/v8kW6QXlZo $JAN #Healthcare

[JanOne @janone]

JanOne Selects Partner for Bottling and Labeling of JAN101 for Peripheral Artery Disease and Potential #COVIDー19 Clinical Trials $JAN #Healthcare #COVID #patients #vascular #PAD #clinicaltrials

Read the full news release here: https://t.co/G5h4UlvI1N